Literature DB >> 23605860

Preliminary results on Ochratoxin A concentrations in blood of patients with various kidney diseases in Germany.

G Schwerdt1, C Schuster, S Silbernagl, M Gareis, M Gekle.   

Abstract

Ochratoxin A (OTA) is supposed to induce renal diseases in man and animals and a correlation between renal diseases and OTA concentration in blood is suspected. Therefore, we measured OTA concentrations in blood of subjects suffering from various renal diseases as e.g. interstitial nephritis or mesangial proliferating glomerular nephritis (GN) and compared them with the blood concentration of healthy individuals. We found OTA in 87% of all samples. There was no significant difference between OTA concentrations of healthy individuals and patients but some renal diseases (e.g. chronic glomerular nephritis) showed increased numbers of samples containing more than 1.5 nmol/l OTA in sera. In contrast, in samples from patients suffering from membranous or focal-sclerotic glomerular nephritis no concentrations above 1.5 nmol/l were found. Our preliminary results show that OTA is abundant in nearly all serum samples but some renal diseases show increased numbers of samples with high (>1.5 nmol/l) OTA concentrations.

Entities:  

Year:  2001        PMID: 23605860     DOI: 10.1007/BF03036424

Source DB:  PubMed          Journal:  Mycotoxin Res        ISSN: 0178-7888            Impact factor:   3.833


  4 in total

1.  Ochratoxin A in human serum samples collected in Isparta-Turkey from healthy individuals and individuals suffering from different urinary disorders.

Authors:  N Ozçelik; A Koşar; D Soysal
Journal:  Toxicol Lett       Date:  2001-04-08       Impact factor: 4.372

2.  [Determination and occurrence of ochratoxin A in slaughtered swine].

Authors:  J Bauer; M Gareis; B Gedek
Journal:  Berl Munch Tierarztl Wochenschr       Date:  1984-08-01       Impact factor: 0.328

3.  Ochratoxin A in human serum samples collected in southern Italy from healthy individuals and individuals suffering from different kidney disorders.

Authors:  A Breitholtz-Emanuelsson; F Minervini; K Hult; A Visconti
Journal:  Nat Toxins       Date:  1994

4.  Ochratoxin A in human blood in relation to nephropathy in Tunisia.

Authors:  K Maaroufi; A Achour; M Hammami; M el May; A M Betbeder; F Ellouz; E E Creppy; H Bacha
Journal:  Hum Exp Toxicol       Date:  1995-07       Impact factor: 2.903

  4 in total
  3 in total

1.  Ochratoxin A is not detectable in renal and testicular tumours.

Authors:  Nader Fahmy; Mark Woo; Mona Alameldin; Kyle Macdonald; Lee W Goneau; Peter Cadieux; Stephen E Pautler
Journal:  Can Urol Assoc J       Date:  2014 Jan-Feb       Impact factor: 1.862

2.  The level of ochratoxin a in patients after nephrectomy.

Authors:  J Grajewski; P Jarzemski; M Twaruzek; K Kuzminska; M Trepala
Journal:  Mycotoxin Res       Date:  2007-03       Impact factor: 3.833

Review 3.  Ochratoxins-food contaminants: impact on human health.

Authors:  Lalini Reddy; Kanti Bhoola
Journal:  Toxins (Basel)       Date:  2010-04-20       Impact factor: 4.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.